Cell-free DNA diagnostic test
Phase 1- Indications
- Rheumatoid arthritis
Company intelligence / Profile preview
Aqtual
Hayward, California, United Statesaqtual.com ↗
- Ownership
- Private
- Employees
- ~30
- Development stage
- Phase 1
01
Overview
Aqtual has developed a proprietary technology that enables comprehensive measurement of gene regulation and epigenetic features using cell-free DNA from blood. Their initial product is a blood test to guide therapy management in rheumatoid arthritis by identifying biomarkers associated with treatment response. Pilot studies have shown promising results; larger prospective studies are underway or planned[1][2].
- Therapeutic areas
- OncologyImmunologyRheumatology
- Modalities
- Blood-based diagnostics (liquid biopsy)Cell-free DNA analysisEpigenetics/transcriptomics profiling from cfDNA[1][2][5]
- Industry
- Molecular Diagnostics
02
Drug pipeline
1 asset03
Partnerships
Genoa Ventures (investor/partner)[2]Manta Ray Ventures (investor/partner)[2]Yu Galaxy (investor/partner)[2]
Beyond the preview
Go deeper on Aqtual.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aqtual.